United States· US:82950-001_8bee41f8-a2d9-44ae-82a9-bd46b6f9916a

OJEMDA

A tovorafenib product containing tovorafenib, registered in United States by Day One Biopharmaceuticals, Inc.. The same ATC class is registered in 9 of our 19 countries.

ATC L01EC04US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedOJEMDAATCL01EC04REGISTER NO.US:82950-001_8bee41f8…PACKS LISTED6CHECKEDSeptember 27, 2026

Where it is registered

Tovorafenib is registered in 9 of 19 countries.

Countries holding a registration under ATC L01EC04 (tovorafenib), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 7 of them publish a price we can compare per daily dose

Tovorafenib · ATC L01EC04

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
TOVORAFENIB
Manufacturer
Day One Biopharmaceuticals, Inc.
Country
United States (US)
ATC code
L01EC04
ATC class
Tovorafenib
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    82950-001-16
  • ndc11
    8295000116
    4 BLISTER PACK in 1 CARTON (82950-001-16) / 4 TABLET, FILM COATED in 1 BLISTER PACK (82950-001-04)
  • ndc11
    8295000120
    4 BLISTER PACK in 1 CARTON (82950-001-20) / 5 TABLET, FILM COATED in 1 BLISTER PACK (82950-001-05)
  • ndc11
    8295000124
    4 BLISTER PACK in 1 CARTON (82950-001-24) / 6 TABLET, FILM COATED in 1 BLISTER PACK (82950-001-06)
  • ndc11
    82950-001-20
  • ndc11
    82950-001-24

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tovorafenib in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tovorafenib products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Ojemda
  • Liechtenstein · Ojemda
  • Norway · Ojemda

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1a6fb512-15ad-4aae-aaa9-97ca7fa60118
GET /v1/drugs/1a6fb512-15ad-4aae-aaa9-97ca7fa60118?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "100",
  "substance": "TOVORAFENIB",
  "productndc": "82950-001",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA217700",
  "marketing_category": "NDA"
}

See everything about tovorafenib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.